Clinical Trial Update: A Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-L1 Positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GEJ) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating toripalimab plus FLOT as perioperative treatment for PD-L1 positive locally advanced resectable gastric cancer or GEJ adenocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• FLOT regimen (Fluorouracil, Leucovorin, Oxaliplatin, Docetaxel)
• Toripalimab (Toripalimab)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: PD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer | Phase 2 | Status: UNKNOWN